156 related articles for article (PubMed ID: 3692611)
21. Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin.
Borrero E; Rossini M
Angiology; 1992 Apr; 43(4):357-61. PubMed ID: 1558322
[TBL] [Abstract][Full Text] [Related]
22. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Shungu DL; Ponticas S; Gill CJ
Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
[TBL] [Abstract][Full Text] [Related]
24. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
King A; Phillips I
J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
Lawrenz CA; Cole P; Theodorou A; Cook RL; Bermann L
Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
[TBL] [Abstract][Full Text] [Related]
26. Association experiments in antimicrobial susceptibility testing of aerobes and anaerobes to ampicillin and ampicillin plus sulbactam.
Heizmann WR; Werner H; Heilmann F
J Chemother; 1989 Jul; 1(4 Suppl):315-6. PubMed ID: 16312418
[No Abstract] [Full Text] [Related]
27. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
Heizmann WR; Heilmann F; Egeler B; Werner H
Infection; 1990; 18(2):117-21. PubMed ID: 2332245
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
Henderson G; Garner J; Morris A
N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Fuchs PC; Barry AL; Jones RN
J Clin Microbiol; 1988 Jun; 26(6):1246-7. PubMed ID: 3384939
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
Dubreuil L; Devos J; Beerens H; Romond C
Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
[TBL] [Abstract][Full Text] [Related]
32. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
33. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
Nord CE; Olsson-Liljequist B
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Brook I
J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
[TBL] [Abstract][Full Text] [Related]
35. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
Jones RN
Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility of anaerobic bacteria in Australia.
Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
[TBL] [Abstract][Full Text] [Related]
37. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
Wells CL; Wilkins TD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibility to Thiamphenicol and Chloramphenicol of Anaerobic Bacteria (author's transl)].
Werner H; Krasemann C; Gorniak W; Hermann A; Ungerechts J
Zentralbl Bakteriol Orig A; 1977; 237(2-3):358-71. PubMed ID: 848218
[TBL] [Abstract][Full Text] [Related]
39. The in vitro activity of trospectomycin against anaerobic bacteria.
Chisari G; Lo Bue AM; Nicoletti G
J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial activity of the sulbactam-ampicillin combination.
Sessarego FV; Botta GA; Pesce A; Schito GC
J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
